ITIM
PCRX icon

Indiana Trust & Investment Management’s Pacira BioSciences PCRX Stock Holding History

Indiana Trust & Investment Management’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$17.2K Hold
760
– – 0.01% 370
2025
Q4 		$19.7K Hold
760
– – 0.01% 352
2025
Q3 		$19.6K Hold
760
– – 0.01% 349
2025
Q2 		$18.2K Hold
760
– – 0.01% 350
2025
Q1 		$18.9K Hold
760
– – 0.01% 347
2024
Q4 		$14.3K Hold
760
– – ﹤0.01% 370
2024
Q3 		$11.4K Hold
760
– – ﹤0.01% 395
2024
Q2 		$21.7K Hold
760
– – 0.01% 330
2024
Q1 		$22.2K Hold
760
– – 0.01% 331
2023
Q4 		$25.6K Hold
760
– – 0.01% 305
2023
Q3 		$23.3K Buy
+760
New +$27.4K 0.01% 311

Other funds holding PCRX

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
DPCM
Doma Perpetual Capital Management Miami, Florida $372M AUM 14.96% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return